Skip to main content
Erschienen in: International Urology and Nephrology 5/2015

01.05.2015 | Urology - Original Paper

Should simultaneous ureteral reimplantation be performed during sigmoid bladder augmentation to reduce vesicoureteral reflux in neurogenic bladder cases?

verfasst von: Peng Zhang, Yong Yang, Zhi-jin Wu, Ning Zhang, Chao-hua Zhang, Xiao-dong Zhang

Erschienen in: International Urology and Nephrology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the necessity of performing simultaneous collateral reimplantation during sigmoid bladder augmentation (SBA) to reduce vesicoureteral reflux (VUR) in low-compliance neuropathic bladder with associated VUR.

Methods

We retrospectively identified 31 patients who underwent SBA alone or with simultaneous ureteral reimplantation at our hospital. The video urodynamics data, VUR status, renal function, and clinical symptoms were studied during follow-up.

Results

The mean follow-up time was 57 months (range 12–117). All patients displayed significantly increased safe cystometric capacity (P < 0.001) and bladder compliance (P < 0.001) and decreased creatinine (P < 0.01) and urea nitrogen (P < 0.05) compared with preoperative levels. High-grade VUR was resolved in only 7 of 15 patients (47 %) in Group A (simultaneous ureteral reimplantation), whereas low-grade VUR was resolved in 13 of 16 patients (81 %) in Group B (SBA alone). The other 11 patients still displaying VUR after SBA had larger safe bladder volumes due to augmentation. The patients’ improving renal function benefited most from the enlarged bladder and partly from increased antireflux resistance of vesico-ureter anastomosis. Twelve (38.7 %) had recurrent febrile urinary tract infection after SBA, and one (3.2 %) suffered from vesico-ureter anastomosis contracture after ureteral reimplantation.

Conclusions

A preoperative intravesical VUR pressure of 20 cmH2O is not an effective cutoff point for whether ureteral reimplantation should be simultaneously performed during SBA. Augmentation appears to be more important than reimplantation for protecting kidney from damage due to febrile urinary tract infection after SBA. Simultaneous reimplantation may be not necessary during SBA in neurogenic bladder.
Literatur
1.
Zurück zum Zitat Biers SM, Venn SN, Greenwell TJ (2012) The past, present and future of augmentation cystoplasty. BJU Int 109:1280–1293CrossRefPubMed Biers SM, Venn SN, Greenwell TJ (2012) The past, present and future of augmentation cystoplasty. BJU Int 109:1280–1293CrossRefPubMed
2.
Zurück zum Zitat Simforoosh N, Tabibi A, Basiri A, Noorbala MH, Danesh AD, Ijadi A (2002) Is ureteral reimplantation necessary during augmentation cystoplasty in patients with neurogenic bladder and vesicoureteral reflux? J Urol 168:1439–1441CrossRefPubMed Simforoosh N, Tabibi A, Basiri A, Noorbala MH, Danesh AD, Ijadi A (2002) Is ureteral reimplantation necessary during augmentation cystoplasty in patients with neurogenic bladder and vesicoureteral reflux? J Urol 168:1439–1441CrossRefPubMed
3.
Zurück zum Zitat López Pereira P, Martinez Urrutia MJ, Lobato Romera R, Jaureguizar E (2001) Should we treat vesicoureteral reflux in patients who simultaneously undergo bladder augmentation for neuropathic bladder? J Urol 165:2259–2261CrossRefPubMed López Pereira P, Martinez Urrutia MJ, Lobato Romera R, Jaureguizar E (2001) Should we treat vesicoureteral reflux in patients who simultaneously undergo bladder augmentation for neuropathic bladder? J Urol 165:2259–2261CrossRefPubMed
4.
Zurück zum Zitat Brereton RJ, Narayanan R, Ratnatunga C (1987) Ureteric re-implantation in the neuropathic bladder. Br J Surg 74:1107–1110CrossRefPubMed Brereton RJ, Narayanan R, Ratnatunga C (1987) Ureteric re-implantation in the neuropathic bladder. Br J Surg 74:1107–1110CrossRefPubMed
5.
Zurück zum Zitat Zhang F, Liao L (2012) Sigmoidocolocystoplasty with ureteral reimplantation for treatment of neurogenic bladder. Urology 80:440–445CrossRefPubMed Zhang F, Liao L (2012) Sigmoidocolocystoplasty with ureteral reimplantation for treatment of neurogenic bladder. Urology 80:440–445CrossRefPubMed
6.
Zurück zum Zitat Soygur T, Burgu B, Zümrütbas A, Suer E (2010) The need for ureteric re-implantation during augmentation cystoplasty: video-urodynamic evaluation. BJU Int 105:530–532CrossRefPubMed Soygur T, Burgu B, Zümrütbas A, Suer E (2010) The need for ureteric re-implantation during augmentation cystoplasty: video-urodynamic evaluation. BJU Int 105:530–532CrossRefPubMed
7.
Zurück zum Zitat Helmy TE, Hafez AT (2013) Vesicouretral reflux with neuropathic bladder: studying the resolution rate after ileocystoplasty. Urology 82:425–429CrossRefPubMed Helmy TE, Hafez AT (2013) Vesicouretral reflux with neuropathic bladder: studying the resolution rate after ileocystoplasty. Urology 82:425–429CrossRefPubMed
8.
Zurück zum Zitat Nagler EV, Williams G, Hodson EM, Craig JC (2011) Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev. 15(6):CD001532 Nagler EV, Williams G, Hodson EM, Craig JC (2011) Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev. 15(6):CD001532
9.
Zurück zum Zitat Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261–274CrossRefPubMed Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261–274CrossRefPubMed
10.
Zurück zum Zitat Flood HD, Ritchey ML, Bloom DA, Huang C, McGuire EJ (1994) Outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring. J Urol 152:1574–1577PubMed Flood HD, Ritchey ML, Bloom DA, Huang C, McGuire EJ (1994) Outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring. J Urol 152:1574–1577PubMed
11.
Zurück zum Zitat Koff SA (1992) Relationship between dysfunctional voiding and reflux. J Urol 148:1703–1705PubMed Koff SA (1992) Relationship between dysfunctional voiding and reflux. J Urol 148:1703–1705PubMed
12.
Zurück zum Zitat Agarwal SK, Khoury AE, Abramson RP, Churchill BM, Argiropoulos G, McLorie GA (1997) Outcome analysis of vesicoureteral reflux in children with myelodysplasia. J Urol 157:980–982CrossRefPubMed Agarwal SK, Khoury AE, Abramson RP, Churchill BM, Argiropoulos G, McLorie GA (1997) Outcome analysis of vesicoureteral reflux in children with myelodysplasia. J Urol 157:980–982CrossRefPubMed
13.
Zurück zum Zitat Juhasz Z, Somogyi R, Vajda P, Oberritter Z, Fathi K, Pinter AB (2008) Does the type of bladder augmentation influence the resolution of pre-existing vesicoureteral reflux? Urodynamic studies. Neurourol Urodyn 27:412–416CrossRefPubMed Juhasz Z, Somogyi R, Vajda P, Oberritter Z, Fathi K, Pinter AB (2008) Does the type of bladder augmentation influence the resolution of pre-existing vesicoureteral reflux? Urodynamic studies. Neurourol Urodyn 27:412–416CrossRefPubMed
14.
Zurück zum Zitat Steyaert H, Gebran S, Moscovici J, Juskiewenski S (1996) Decisional criteria in the management of vesico-ureteral reflux in children with congenital neurogenic bladder. Prog Urol 6:76–80PubMed Steyaert H, Gebran S, Moscovici J, Juskiewenski S (1996) Decisional criteria in the management of vesico-ureteral reflux in children with congenital neurogenic bladder. Prog Urol 6:76–80PubMed
15.
Zurück zum Zitat Hendren WH, Hendren RB (1990) Bladder augmentation: experience with 129 children and young adults. J Urol 144:445–453PubMed Hendren WH, Hendren RB (1990) Bladder augmentation: experience with 129 children and young adults. J Urol 144:445–453PubMed
16.
Zurück zum Zitat Cohen RA, Rushton HG, Belman AB, Kass EJ, Majd M, Shaer C (1990) Renal scarring and vesicoureteral reflux in children with myelodysplasia. J Urol 144:541–544PubMed Cohen RA, Rushton HG, Belman AB, Kass EJ, Majd M, Shaer C (1990) Renal scarring and vesicoureteral reflux in children with myelodysplasia. J Urol 144:541–544PubMed
17.
Zurück zum Zitat Gladman MA, Scott SM, Lunniss PJ, Williams NS (2005) Systematic review of surgical options for idiopathic megarectum and megacolon. Ann Surg 241:562–574CrossRefPubMedCentralPubMed Gladman MA, Scott SM, Lunniss PJ, Williams NS (2005) Systematic review of surgical options for idiopathic megarectum and megacolon. Ann Surg 241:562–574CrossRefPubMedCentralPubMed
Metadaten
Titel
Should simultaneous ureteral reimplantation be performed during sigmoid bladder augmentation to reduce vesicoureteral reflux in neurogenic bladder cases?
verfasst von
Peng Zhang
Yong Yang
Zhi-jin Wu
Ning Zhang
Chao-hua Zhang
Xiao-dong Zhang
Publikationsdatum
01.05.2015
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 5/2015
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-0958-4

Weitere Artikel der Ausgabe 5/2015

International Urology and Nephrology 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.